<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested the hypothesis that plasma brain natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (BNP) levels are elevated in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular diseases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) independent of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, and reflect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> severity </plain></SENT>
<SENT sid="1" pm="."><plain>After careful evaluations for <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, the study included 79 consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> without any evidence of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> admitted within 48 h after <z:hpo ids='HP_0003674'>onset</z:hpo> (71+/-10 years), and 26 control subjects without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (CT, 67+/-12 years) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> subtypes were defined by the TOAST classification </plain></SENT>
<SENT sid="3" pm="."><plain>Large-artery <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (LAA, n=27), small-<z:mp ids='MP_0006134'>artery occlusion</z:mp> (SAO, n=27), and <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>, n=25) were included </plain></SENT>
<SENT sid="4" pm="."><plain>The plasma BNP levels were measured at admission and 1 month later </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> severity and brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant differences in the clinical profiles including echocardiographic parameters among the groups </plain></SENT>
<SENT sid="7" pm="."><plain>The plasma BNP level (pg/mL) upon admission was higher in LAA (70.6+/-53.9) than in SAO (38.2+/-28.4) and CT (28.5+/-19.9) (both p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The level in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (47.3+/-28.6) was not significantly different from that in CT </plain></SENT>
<SENT sid="9" pm="."><plain>The BNP level in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was positively correlated with the NIH <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) (rho=0.42, p&lt;0.05) and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (r=0.34, p&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and NIHSS were independent contributors to the plasma BNP level in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>One month later, the BNP level was significantly decreased and was similar in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> groups </plain></SENT>
<SENT sid="12" pm="."><plain>The plasma BNP level transiently increased in patients with LAA independently of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, and reflected <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and the severity of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>